Etfdb logo
  • ETF
  • CURE
    Pricing Data
    $53.34
    Change: $1.77 (0.03%)
    Time: 01/18/19
    Previous Close: $51.57
  • Category
  • Leveraged Equities
Last Updated:

Profile

Vitals

Trading Data

Open: - Volume -
Day Lo - Day Hi -
  • 52 Week Lo: $38.59
  • 52 Week Hi: $68.37
  • AUM: $160.0 M
  • Shares: 3.0 M

Investment Themes

Historical Trading Data

  • 1 Month Avg. Volume: 370,927
  • 3 Month Avg. Volume: 263,041

Alternative ETFs in the Leveraged Equities Category

Type Ticker Expense Ratio Assets Avg. Daily Vol YTD Return
Cheapest FRLG $458.0 M 42,381 14.65%
Largest (AUM) TQQQ 0.95% $3,685.8 M 22,922,242 21.25%
Most Liquid (Volume) SQQQ 0.95% $919.9 M 43,867,536 -20.53%
Top YTD Performer XCOM 0.95% $4.1 M 10,343 642757.13%

Analyst Report

This ETF offers 3x daily leveraged exposure to an index consisting of healthcare stocks, including companies engaged in the manufacture of health care products and materials, and those responsible for providing health-related services. Given the narrow focus and the leveraged exposure, CURE doesn't belong in any long-term, buy-and-hold portfolios; this ETF is designed for risk-tolerant investors looking to express a bullish outlook on a specific sector of the U.S. economy over a relatively short period of time. Investors looking to establish a non-leveraged tilt towards health care stocks have a number of choices in the Health & Biotech Equities ETFdb Category, including XLV (which is linked to the same index as this product). Investors considering this leveraged ETF should understand the impact that the daily reset feature has on the risk/return profile. CURE is designed to offer 3x leveraged exposure over the course of a single trading session only; those holding this fund for longer or shorter than this time period may experience returns that vary (sometimes significantly) from the target multiple. CURE can still be used effectively as part of longer-term strategies; investors must simply understand the nuances of compounding returns in a daily reset fund, and be willing/able to monitor and rebalance as needed. Investors looking to make a leveraged bet against health care stocks have SICK available, while those seeking 2x exposure may prefer RXL (long) or RXD (short).

Realtime Rating

Sign Up for Pro to Unlock Data Sign Up

Realtime Rating Summary

The adjacent table gives investors an individual Realtime Rating for CURE on several different metrics, including liquidity, expenses, performance, volatility, dividend, concentration of holdings in addition to an overall rating. The "A+ Metric Rated ETF" field, available to ETFdb Pro members, shows the ETF in the Leveraged Equities with the highest Metric Realtime Rating for each individual field. To view all of this data, sign up for a free 14-day trial for ETFdb Pro. To view information on how the ETFdb Realtime Ratings work, click here.

Compare to another ETF

View the Category Report

CURE Overall Realtime Rating:

A+ Overall Rated ETF:

Metric Metric Realtime Rating A+ Metric Rated ETF
Liquidity A- n/a
Expenses A- n/a
Performance
Volatility
Dividend
Concentration

CURE In-Depth Analysis

The following tables and charts contain in-depth metrics for this ETF and compare it to similar peer ETFs within its ETFdb.com Category.

CURE Holdings

Filings Data as of: Jan 18, 2019

All 2 Holdings

Concentration Analysis

This section compares how balanced and deep this ETF is relative to the peer group ETFdb.com Category.

Number of Holdings
Rank: 121 of 150
2
Category Low TECS (1)
Category High TWM (2017)
% Assets in Top 10
Rank: 139 of 150
100.00%
Category Low SRTY (2.92%)
Category High FNGD (112.89%)

CURE Expenses & Fees

This section compares the cost efficiency of this ETF to peers in the same ETFdb.com Category.

Expenses Ratio Analysis

ETF Average
0.545%
ETF Wtd. Average
0.21%
Category Average
0.97%
Expense Ratio
Rank: 125 of 159
1.09%
Category Low FIEG (0.10%)
Category High INDL (1.36%)

Commission Free Trading

This ETF is not currently available for commission free trading on any platforms.

Category Commission Free Trading

There are 25 other ETFs in the Leveraged Equities ETFdb.com Category that are also eligible for commission free trading:

CURE ESG Themes and Scores

CURE does not have an ESG score. There are no ESG themes that map to this ETF.

CURE Performance

This section shows how this ETF has performed relative to its peer group ETFdb.com Category.

1 Week Return
Rank: 25 of 155
7.63%
Category Low WDRW (-17.34%)
Category High XCOM (642757.13%)
4 Week Return
Rank: 45 of 155
26.84%
Category Low LABD (-55.88%)
Category High XCOM (642757.13%)
13 Week Return
Rank: 90 of 150
-8.57%
Category Low GUSH (-57.96%)
Category High XCOM (337400.00%)
26 Week Return
Rank: 31 of 148
5.75%
Category Low GUSH (-66.62%)
Category High XCOM (622976.94%)
Year to Date Return
Rank: 73 of 155
12.08%
Category Low GASX (-44.26%)
Category High XCOM (642757.13%)
1 Year Return
Rank: 43 of 138
-4.70%
Category Low NAIL (-70.82%)
Category High XCOM (224900.02%)
3 Year Return
Rank: 31 of 123
103.61%
Category Low JDST (-99.22%)
Category High XCOM (949.22%)
5 Year Return
Rank: 8 of 97
186.59%
Category Low GASL (-99.95%)
Category High SOXL (464.93%)

CURE Fund Flows

This section compares the fund flows of this ETF to peers in the same ETFdb.com Category.

1 Week Fund Flow
Rank: N/A
No Ranking Available
Category Low TQQQ (‑$53.0 M)
Category High SQQQ ($88.4 M)
4 Week Fund Flow
Rank: 43 of 115
$2.7 M
Category Low TQQQ (‑$292.1 M)
Category High SQQQ ($457.6 M)
13 Week Fund Flow
Rank: 22 of 135
$16.9 M
Category Low NUGT (‑$178.6 M)
Category High TQQQ ($498.2 M)
26 Week Fund Flow
Rank: 28 of 147
$23.7 M
Category Low TZA (‑$155.7 M)
Category High TQQQ ($1,427.8 M)
Year to Date Fund Flow
Rank: 27 of 109
$7.3 M
Category Low TQQQ (‑$301.3 M)
Category High SQQQ ($434.5 M)
1 Year Fund Flow
Rank: 49 of 153
$10.1 M
Category Low DUST (‑$417.4 M)
Category High FIYY ($1,402.8 M)
3 Year Fund Flow
Rank: 144 of 154
‑$193.7 M
Category Low FAS (‑$846.2 M)
Category High TQQQ ($1,736.6 M)
5 Year Fund Flow
Rank: 144 of 154
‑$42.9 M
Category Low SSO (‑$2,462.3 M)
Category High TQQQ ($2,245.4 M)

Brought to You by Mitre Media


Charts

The following charts can be customized to display historical performance in a number of different formats, including line charts, bar charts, and candlesticks. Time periods can be adjusted to increase or decrease the period shown, ranging from five minutes to several months.

The following chart also includes the option to compare the performance of CURE relative to other ETFs and benchmarks or to include indicators such as Bollinger Bands, relative strength, and moving averages.

CURE Valuation

This section shows how the P/E multiple of this ETF compares to the peer group ETFdb.com Category.

P/E Ratio
Rank: 52 of 69
17.18
Category Low RUSL (5.45)
Category High GDXX (26.63)

CURE Dividend

This section shows how the dividend yield of this ETF compares to the peer group ETFdb.com Category.

Dividend
$0.14
Dividend Date
2018-12-27
Annual Dividend Rate
$0.33
Annual Dividend Yield
Rank: 76 of 129
0.65%
Category Low ZBIO (0.03%)
Category High AMJL (18.15%)

CURE Technicals

Volatility Analysis

This section shows how the volatility of this ETF compares to the peer group ETFdb.com Category.

5 Day Volatility
Rank: 19 of 155
385.22%
Category Low PPEM (10.68%)
Category High XCOM (5855.19%)
20 Day Volatility
Rank: 51 of 155
76.72%
Category Low PPEM (20.83%)
Category High XCOM (3057.23%)
50 Day Volatility
Rank: 56 of 150
71.05%
Category Low PPDM (23.15%)
Category High XCOM (2043.23%)
200 Day Volatility
Rank: 64 of 148
60.93%
Category Low PPDM (21.13%)
Category High XCOM (1481.94%)
Beta
Rank: 27 of 147
2.96
Category Low FNGU (-7.83)
Category High FNGD (7.78)
Standard Deviation
Rank: 54 of 138
7.11%
Category Low LBDC (1.01%)
Category High SOXL (31.10%)

Technicals

  • 20 Day MA: $46.95
  • 60 Day MA: $52.86
  • MACD 15 Period: 5.06
  • MACD 100 Period: -3.22
  • Williams % Range 10 Day: 0.42
  • Williams % Range 20 Day: 0.21
  • RSI 10 Day: 64
  • RSI 20 Day: 54
  • RSI 30 Day: 51
  • Ultimate Oscillator: 67

Bollinger Brands

  • Lower Bollinger (10 Day): $46.23
  • Upper Bollinger (10 Day): $52.53
  • Lower Bollinger (20 Day): $40.48
  • Upper Bollinger (20 Day): $53.10
  • Lower Bollinger (30 Day): $39.44
  • Upper Bollinger (30 Day): $58.85

Support & Resistance

  • Support Level 1: $52.08
  • Support Level 2: $50.83
  • Resistance Level 1: $53.98
  • Resistance Level 2: $54.63

Stochastic

  • Stochastic Oscillator %D (1 Day): 71.54
  • Stochastic Oscillator %D (5 Day): 87.43
  • Stochastic Oscillator %K (1 Day): 62.44
  • Stochastic Oscillator %K (5 Day): 82.16

Fact Sheet

Fact sheets are issued by the ETF provider and framed by ETFdb.com. Information contained within the fact sheet is not guaranteed to be timely or accurate.

Source: LSEG Information Services (US), Inc. (“LSEG”) © LSEG 2016. All rights in the XTF data, ratings and / or underlying data contained in this communication (“the XTF information”) vest in LSEG and/or its licensors. Neither LSEG nor its licensors accept any liability arising out of the use of, reliance on or any errors or omissions in the XTF information. No further distribution of the XTF information is permitted without LSEG’s express written consent. LSEG does not promote, sponsor or endorse the content of this communication.

Copyright MSCI ESG Research LLC [2018]. All Rights Reserved. MSCI ESG Research LLC’s (“MSCI ESG”) Fund Metrics products (the “Information”) provide environmental, social and governance data with respect to underlying securities within more than 23,000 multi-asset class Mutual Funds and ETFs globally. MSCI ESG is a Registered Investment Adviser under the Investment Advisers Act of 1940. MSCI ESG materials have not been submitted, to nor received approval from, the US SEC or any other regulatory body. None of the information constitutes an offer to buy or sell, or a promotion or recommendation of, any security, financial instrument or product or trading strategy, nor should it be taken as an indication or guarantee of any future performance, analysis, forecast or prediction. None of the Information can be used to determine which securities to buy or sell or when to buy or sell them. The Information is provided “as is” and the user of the Information assumes the entire risk of any use it may make or permit to be made of the Information. All Information is provided solely for your internal use, and may not be reproduced or redisseminated in any form without express prior written permission from MSCI. Neither MSCI ESG nor any of its affiliates or any third party involved in or related to creating any Information makes any express or implied warranties, representations or guarantees, and in no event will MSCI ESG or any such affiliate or third party have any liability for any direct, indirect, special, punitive, consequential or any other damages (including lost profits) relating to any Information. More information on MSCI ESG Fund Metrics, provided by MSCI ESG Research LLC, can be found at https://www.msci.com/esg-fund-metrics.
© 2019 Market data provided is at least 15-minutes delayed and hosted by Barchart Solutions.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use, please see disclaimer.